Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/10/2026 | Q4 | $12B | -- | -- | $0.56 | -- |
| 10/21/2025 | Q3 | $12.4B | $12.6B | $0.86 | $0.78 | $0.08 |
| 07/22/2025 | Q2 | $12.6B | $12.7B | $0.88 | $0.84 | $0.05 |
| 04/29/2025 | Q1 | $11.2B | $11.2B | $0.77 | $0.72 | $0.06 |
| 02/11/2025 | Q4 | $10.7B | $11.3B | $0.51 | $0.52 | -$0.01 |
| 10/23/2024 | Q3 | $11.6B | $11.9B | $0.66 | $0.75 | -$0.09 |
| 07/23/2024 | Q2 | $11.8B | $12.3B | $0.56 | $0.81 | -$0.25 |
| 04/30/2024 | Q1 | $11B | $11.3B | $0.74 | $0.70 | $0.04 |
| 02/13/2024 | Q4 | $10.7B | $10.9B | $0.46 | $0.49 | -$0.03 |
| 10/24/2023 | Q3 | -- | $12B | $0.71 | -- | -- |
| 07/26/2023 | Q2 | -- | $12B | $0.59 | -- | -- |
| 04/24/2023 | Q1 | -- | $11B | $0.72 | -- | -- |
| 02/14/2023 | Q4 | -- | $9.8B | $0.47 | -- | -- |
| 10/25/2022 | Q3 | -- | $11.1B | $0.65 | -- | -- |
| 07/26/2022 | Q2 | -- | $11.4B | $0.44 | -- | -- |
| 04/25/2022 | Q1 | -- | $10.5B | $0.64 | -- | -- |
| 02/10/2022 | Q4 | -- | $9.5B | $0.56 | -- | -- |
| 10/27/2021 | Q3 | -- | $10.1B | $0.57 | -- | -- |
| 07/21/2021 | Q2 | -- | $10.2B | $0.61 | -- | -- |
| 04/19/2021 | Q1 | -- | $9B | $0.52 | -- | -- |
| 02/10/2021 | Q4 | -- | $8.7B | $0.34 | -- | -- |
| 10/22/2020 | Q3 | -- | $8.7B | $0.40 | -- | -- |
| 07/21/2020 | Q2 | -- | $7.1B | $0.41 | -- | -- |
| 04/21/2020 | Q1 | -- | $8.6B | $0.64 | -- | -- |
| 01/30/2020 | Q4 | -- | $9.1B | $0.47 | -- | -- |
| 10/18/2019 | Q3 | -- | $9.5B | $0.60 | -- | -- |
| 07/23/2019 | Q2 | -- | $10B | $0.61 | -- | -- |
| 04/23/2019 | Q1 | -- | $8.7B | $0.39 | -- | -- |
| 02/14/2019 | Q4 | -- | $7.8B | $0.20 | -- | -- |
| 10/30/2018 | Q3 | -- | $8.7B | $0.44 | -- | -- |
| 07/25/2018 | Q2 | -- | $9.3B | $0.54 | -- | -- |
| 04/24/2018 | Q1 | -- | $7.6B | $0.32 | -- | -- |
| 02/13/2018 | Q4 | -- | $7.4B | -$0.65 | -- | -- |
| 10/25/2017 | Q3 | -- | $9B | $0.34 | -- | -- |
| 07/26/2017 | Q2 | -- | $9.6B | $0.32 | -- | -- |
| 04/25/2017 | Q1 | -- | $9B | $0.27 | -- | -- |
| 02/09/2017 | Q4 | -- | $9.3B | $0.13 | -- | -- |
| 10/26/2016 | Q3 | -- | $10.5B | $0.24 | -- | -- |
| 07/27/2016 | Q2 | -- | $11.4B | $0.79 | -- | -- |
| 04/20/2016 | Q1 | -- | $10.2B | $0.34 | -- | -- |
| 02/09/2016 | Q4 | -- | $9.8B | $0.28 | -- | -- |
The Coca-Cola Co. reported $12.6B worth of top line sales in its most recent quarter.
The Coca-Cola Co. announced earnings per share of $0.86 which represents a beat of analyst forecast a $0.78 per share.
The Coca-Cola Co. reported $7.7B that represents $1.79 per share over the last quarter.
The Coca-Cola Co.'s earnings are forecast to grow from $2.46 per share to $2.85 per share next year representing an increase of 21.41%.
The Coca-Cola Co.'s next earnings date is February 10, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.